Chromatin regulated interchange between polycomb repressive complex 2 (PRC2)-Ezh2 and PRC2-Ezh1 complexes controls myogenin activation in skeletal muscle cells

被引：0
|
作者：
Lovorka Stojic
Zuzana Jasencakova
Carolina Prezioso
Alexandra Stützer
Beatrice Bodega
Diego Pasini
Rebecca Klingberg
Chiara Mozzetta
Raphael Margueron
Pier Lorenzo Puri
Dirk Schwarzer
Kristian Helin
Wolfgang Fischle
Valerio Orlando
机构：
[1] Dulbecco Telethon Institute,Department of Oncology
[2] IRCCS Fondazione Santa Lucia,Biotech Research and Innovation Centre (BRIC)
[3] University of Cambridge,Laboratory of Chromatin Biochemistry
[4] Cancer Research UK Cambridge Research Institute,Department of Biology and Genetics for Medical Sciences
[5] University of Copenhagen,Department of Experimental Oncology
[6] Max Planck Institute for Biophysical Chemistry,Department of Chemical Biology/Protein Chemistry
[7] University of Milan,undefined
[8] European Institute of Oncology,undefined
[9] c/o IFOM-IEO Campus,undefined
[10] Leibniz-Institut fuer Molekulare Pharmakologie (FMP),undefined
[11] Universitè Paris Diderot Paris 7,undefined
[12] CNRS,undefined
[13] Curie Institute,undefined
[14] Unité de Génétique et Biologie du Développement,undefined
[15] The Sanford Burnham Institute,undefined
来源：
Epigenetics & Chromatin | / 4卷
关键词：
C2C12 Cell; Myogenic Differentiation; Skeletal Muscle Differentiation; Chick Embryo Extract; Human Primary Myoblast;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Dysregulation of Polycomb Repressive Complex 2 (PRC2) Activity in Huntington's Disease
    Fenster, Robert J.
    Heilbut, Adrian M.
    Kulicke, Ruth
    Hachigian, Lea J.
    Shema, Reut
    Mesirov, Jill P.
    Kolaczyk, Eric D.
    Greengard, Paul
    Heiman, Myriam
    BIOLOGICAL PSYCHIATRY, 2015, 77 (09) : 413S - 413S
  • [32] Interplay of Fra-2/AP-1 and Ezh2/PRC2 orchestrates epidermal differentiation
    Wurm, Stefanie
    Guinea-Viniegra, Juan
    Zhang, Jisheng
    Ezhkova, Elena
    Wagner, Erwin Friedrich
    CANCER RESEARCH, 2014, 74 (19)
  • [33] A cytosolic Ezh1 isoform modulates a PRC2-Ezh1 epigenetic adaptive response in postmitotic cells
    Bodega, Beatrice
    Marasca, Federica
    Ranzani, Valeria
    Cherubini, Alessandro
    Della Valle, Francesco
    Neguembor, Maria Victoria
    Wassef, Michel
    Zippo, Alessio
    Lanzuolo, Chiara
    Pagani, Massimiliano
    Orlando, Valerio
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2017, 24 (05) : 444 - +
  • [34] HIFI-α activation underlies a functional switch in the paradoxical role of Ezh2/PRC2 in breast cancer
    Mahara, Sylvia
    Lee, Puay Leng
    Feng, Min
    Tergaonkar, Vinay
    Chng, Wee Joo
    Yu, Qiang
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (26) : E3735 - E3744
  • [35] EED-Targeted PROTACs Degrade EED, EZH2, and SUZ12 in the PRC2 Complex
    Hsu, Jessie Hao-Ru
    Rasmusson, Timothy
    Robinson, James
    Pachl, Fiona
    Read, Jon
    Kawatkar, Sameer
    O'Donovan, Daniel H.
    Bagal, Sharan
    Code, Erin
    Rawlins, Philip
    Argyrou, Argyrides
    Tomlinson, Ronald
    Gao, Ning
    Zhu, Xiahui
    Chiarparin, Elisabetta
    Jacques, Kelly
    Shen, Minhui
    Woods, Haley
    Bednarski, Emma
    Wilson, David M.
    Drew, Lisa
    Castaldi, M. Paola
    Fawell, Stephen
    Bloecher, Andrew
    CELL CHEMICAL BIOLOGY, 2020, 27 (01): : 41 - +
  • [36] Akt Inhibition Differently Controls PRC2 Components and Synergizes with Dual EZH2/1 Inhibitor in the Treatment of Multiple Myeloma
    Rizk, Mohamed
    Rizq, Ola
    Oshima, Motohiko
    Nakajima-Takagi, Yaeko
    Koide, Shuhei
    Saraya, Atsunori
    Isshiki, Yusuke
    Chiba, Tetsuhiro
    Yamazaki, Satoshi
    Ma, Anqi
    Jin, Jian
    Iwama, Atsushi
    Mimura, Naoya
    BLOOD, 2019, 134
  • [37] Association of BMI1 with polycomb bodies is dynamic and requires PRC2/EZH2 and the maintenance DNA methyltransferase DNMT1
    Hernández-Muñoz, I
    Taghavi, P
    Kuijl, C
    Neefjes, J
    van Lohuizen, M
    MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (24) : 11047 - 11058
  • [38] Genetic defects in PRC2 components other than EZH2 are not common in myeloid malignancies
    Kroeze, Leonie I.
    Nikoloski, Gorica
    da Silva-Coelho, Pedro
    van Hoogen, Patricia
    Stevens-Linders, Ellen
    Kuiper, Roland P.
    Schnittger, Susanne
    Haferlach, Torsten
    Pahl, Heike L.
    van der Reijden, Bert A.
    Jansen, Joop H.
    BLOOD, 2012, 119 (05) : 1318 - 1319
  • [39] DNA Methylation Signature for EZH2 Functionally Classifies Sequence Variants in Three PRC2 Complex Genes
    Choufani, Sanaa
    Gibson, William T.
    Turinsky, Andrei L.
    Chung, Brian H. Y.
    Wang, Tianren
    Garg, Kopal
    Vitriolo, Alessandro
    Cohen, Ana S. A.
    Cyrus, Sharri
    Goodman, Sarah
    Chater-Diehl, Eric
    Brzezinski, Jack
    Brudno, Michael
    Ming, Luk Ho
    White, Susan M.
    Lynch, Sally Ann
    Clericuzio, Carol
    Temple, I. Karen
    Flinter, Frances
    McConnell, Vivienne
    Cushing, Tom
    Bird, Lynne M.
    Splitt, Miranda
    Kerr, Bronwyn
    Scherer, Stephen W.
    Machado, Jerry
    Imagawa, Eri
    Okamoto, Nobuhiko
    Matsumoto, Naomichi
    Testa, Guiseppe
    Iascone, Maria
    Tenconi, Romano
    Caluseriu, Oana
    Mendoza-Londono, Roberto
    Chitayat, David
    Cytrynbaum, Cheryl
    Tatton-Brown, Katrina
    Weksberg, Rosanna
    AMERICAN JOURNAL OF HUMAN GENETICS, 2020, 106 (05) : 596 - 610
  • [40] Cryptic RNA-binding by PRC2 components EZH2 and SUZ12
    Betancur, Juan G.
    Tomari, Yukihide
    RNA BIOLOGY, 2015, 12 (09) : 959 - 965
12345